The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Mechanism of Tau hyperphosphorylation involving lysosomal enzyme asparagine endopeptidase in a mouse model of brain ischemia.
Abstract
Dementias including Alzheimer’s disease (AD) are multifactorial disorders that involve several different etiopathogenic mechanisms. Cerebral ischemia has been suspected in the altered regulation of protein kinases and phosphatases that leads to hyperphosphorylation of tau and further neurofibrillary pathology, a key hallmark of AD and related neurodegenerative diseases. However, the deregulation of these enzymes and their relationship with ischemia and AD remain unclear. Previously, we reported a mechanism by which the lysosomal enzyme asparagine endopeptidase (AEP) is associated with brain acidosis and AD. In this study, we subjected mice to middle cerebral artery occlusion and found that compared with wild type mice, the ischemia-induced brain injury and motor deficit in AEP-knockout mice are reduced, probably because ischemia activates AEP. AEP cleaves inhibitor 2 of protein phosphatase 2A (I 2 PP2A), which translocates from the neuronal nucleus to the cytoplasm and produces hyperphosphorylation of tau through inhibition of PP2A. These findings suggest a possible mechanism of tau pathology associated with ischemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PP2A is a key phosphatase that limits Tau hyperphosphorylation in vitro and in vivo.
“a key phosphatase that limits Tau hyperphosphorylation both in vitro (Basurto-Islas et al., 2013) and in vivo (Basurto-Islas et al., 2018).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Basurto-Islas et al., 2018
Under acidic conditions such as brain ischemia, hypoxia, or AD, legumain can translocate from neuronal lysosomes into the cytoplasm.
“Under acidic conditions (e.g., brain ischemia, hypoxia, or AD), legumain can translocate from neuronal lysosomes into the cytoplasm”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Basurto-Islas et al., 2018
Citations
Cites
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
Bennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184
Flagged first, then by citations
Research works printed but not linked: 59
- 10.1016/j.neurobiolaging.2005.10.004 · DOI · Paper page
- 10.1074/jbc.M311768200 · DOI
- 10.1016/j.brainres.2004.05.106 · DOI
- 10.1001/jama.292.23.2901 · DOI
- 10.1016/j.jns.2008.03.006 · DOI · Paper page
- 10.3233/JAD-140144 · DOI
- 10.1016/S0021-9258(17)38495-8 · DOI
- 10.1073/pnas.83.13.4913 · DOI · Paper page
- 10.1074/jbc.M110.110957 · DOI · Paper page
- 10.1073/pnas.94.1.298 · DOI · Paper page
- 10.1073/pnas.91.12.5562 · DOI · Paper page
- 10.1038/nm0796-783 · DOI · Paper page
- 10.1517/14728222.2014.870156 · DOI
- 10.1007/s00401-009-0486-3 · DOI · Paper page
- 10.1016/S1471-4914(01)02266-3 · DOI
- 10.1074/jbc.M006219200 · DOI
- 10.1111/j.1460-9568.2005.04391.x · DOI · Paper page
- 10.1016/j.febslet.2004.11.097 · DOI · Paper page
- 10.1016/S0002-9440(10)62486-8 · DOI · Paper page
- 10.1016/j.febslet.2011.07.020 · DOI
- 10.1096/fj.10-158477 · DOI
- 10.1074/jbc.M112.446070 · DOI · Paper page
- 10.1038/nm.3700 · DOI · Paper page
- 10.1016/j.molcel.2008.02.017 · DOI
- 10.1074/jbc.M305930200 · DOI
- 10.1016/j.brainres.2013.11.004 · DOI
- 10.1074/jbc.M302742200 · DOI
- 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
- 10.1080/01616412.1997.11740874 · DOI
- 10.1161/01.STR.20.1.84 · DOI · Paper page
- 10.1074/jbc.270.32.18917 · DOI · Paper page
- 10.1152/physrev.1999.79.4.1431 · DOI · Paper page
- 10.1212/WNL.44.10.1885 · DOI
- 10.1016/S0006-8993(99)02113-7 · DOI
- 10.1016/S0272-2712(18)30290-7 · DOI
- Song B, 2013, Neural Regen Res, 8, 3173, 10.4103/1673-5374.121652 · DOI
- 10.1038/jcbfm.2010.39 · DOI
- 10.1159/000112845 · DOI
- 10.1073/pnas.0809824105 · DOI
- 10.1523/JNEUROSCI.22-23-10291.2002 · DOI
- 10.1016/j.biochi.2015.09.022 · DOI
- 10.1093/jnci/dju012 · DOI
- Liu C, 2003, Cancer Res, 63, 2957
- 10.1002/jcb.24143 · DOI
- 10.1371/journal.pone.0052980 · DOI
- 10.1007/s10549-006-9311-z · DOI
- 10.1002/pmic.201200006 · DOI
- 10.1038/ncomms9762 · DOI · Paper page
- 10.1038/sj.emboj.7601518 · DOI
- Lam BD, 2012, Cytometry A, 81, 81
- 10.1016/j.febslet.2011.07.020 · DOI
- 10.1016/0006-8993(95)00417-O · DOI
- 10.1097/00004647-200003000-00013 · DOI
- 10.1161/01.STR.15.1.5 · DOI
- 10.1161/01.STR.29.3.705 · DOI · Paper page
- 10.1016/j.neulet.2011.03.034 · DOI
- 10.1371/journal.pone.0051552 · DOI
- 10.1155/2014/962343 · DOI
- 10.1096/fj.10-158477 · DOI
Cited by
Sorted by citations
Chen, C., Ahn, E. H., Kang, S. S., Liu, X., Alam, A., & Ye, K. (2020) · Science Advances · doi:10.1126/sciadv.aba0466 · Cited by 205
García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 88
Association of small vessel disease with tau pathology
Kapasi, A., Yu, L., Petyuk, V., Arfanakis, K., Bennett, D. A., & Schneider, J. A. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02397-x · Cited by 55
Chen, G., Kang, S. S., Wang, Z., Ahn, E. H., Xia, Y., Liu, X., Sandoval, I. M., Manfredsson, F. P., Zhang, Z., & Ye, K. (2021) · Science Advances · doi:10.1126/sciadv.abe4499 · Cited by 44
Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease
Nichols, J. B., Malek-Ahmadi, M., Tariot, P. N., Serrano, G. E., Sue, L. I., & Beach, T. G. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa160 · Cited by 22
Metadata
- Authors
- Basurto-Islas, G., Gu, J.-H., Tung, Y. C., Liu, F., & Iqbal, K.
- Affiliations
- Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2018-04-24
- Volume
- 63
- Issue
- 2
- Pages
- 821-833
- ISSN
- 1387-2877
- 1875-8908
- Cited by
- 39
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review